Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Namuscla 167 mg hard capsules-Educational Guide-Minimising the risks of cardiac arrhythmia and severity of adverse reactions in those with hepatic impairment

Important information on minimising the risks of cardiac arrhythmia and severity of adverse reactions in those with hepatic impairment

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.